All eyes in the health care cannabis sector are observing a December deadline faced by Congress. A shorter-phrase funding deal signed into law on September eight by President Donald Trump not only kept the governing administration operating, it also preserved an present provision identified as the Rohrabacher-Blumenauer Amendment that prohibited the Section of Justice from interfering with condition healthcare cannabis guidelines. That offer will expire on December eight, and Congress will have to approve a new variation of the modification if the protections are to stay in the next spending bill.

LEAVE A REPLY

Please enter your comment!
Please enter your name here